OGX-427 in Castration Resistant Prostate Cancer Patients
|2||Not yet recruiting||
Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
Active, not recruiting
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
† Study has passed its completion date and status has not been verified in more than two years.